Discover trends, market shifts, and competitive outlooks for the antibiotic resistance industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Anticipated CAGR of the Antibiotic Resistance Market, and What Factors Will Drive It?
The market size for antibiotic resistance has significantly expanded over the recent years. It’s projected to escalate from $12.21 billion in 2024 to $12.89 billion in 2025, experiencing a compound annual growth rate (CAGR) of 5.6%. The substantial growth during the historical period can be associated with the scarcity of new antibiotics, the frequent and excessive usage of antimicrobials in humans, animals, and plants, the presence of heavily polluted waste effluents, diminishing vaccination rates, and a deficiency of diagnostic instruments.
The market size for antibiotic resistance is predicted to observe substantial expansions in the coming years, reaching $16.97 billion by 2029 with a compound annual growth rate (CAGR) of 7.1%. The growth during the forecast period is due to factors such as incomplete treatment courses, global travel and globalization, inadequate infection prevention and control practices, self-medication, transmission across species, and high population density. Key trends anticipated in the forecast period are advancements in drug delivery technology, worldwide cooperation for monitoring, the growing significance of artificial intelligence, and a rise in new therapy approaches.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12131&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Antibiotic Resistance Market?
The antibiotic-resistance market is likely to experience significant growth due to the increasing occurrence of drug-resistant infections. These infections are triggered by resistant bacteria which make the disease significantly challenging or even impossible to treat. Antimicrobial resistance drugs are beneficial in addressing these drug-resistant infections as they ameliorate antibiotic treatment results involving both target and non-target pathogens, depending on the specifics of resistance mechanisms and the interaction structure of the microbiome community. As demonstrated by data from November 2023, the UK Health Security Agency, a government organization based in the UK, revealed in their report that an estimated 58,224 people in England were presumed to have undergone an antibiotic-resistant infection in 2022. This depicts a 4% surge from the 55,792 cases documented in 2021. Consequently, the widespread prevalence of drug resistance infection is fueling the growth of the antibiotic resistance market.
Which Primary Segments of the Antibiotic Resistance Market Are Driving Growth and Industry Transformations?
The antibiotic resistance market covered in this report is segmented –
1) By Drug Class: Beta Lactum Antibiotic, Cephalosporins, Quinolones Antibiotics, Macrolide Antibiotics, Tetracyclines, Oxazolidinones, Other Drug Classes
2) By Pathogen: Staphylococcus Aureus, Staphylococcus Pneumonia, Neisseria Gonorrhoeae, Enterococcus Faecium, Escherichia Coli, Klebsiella Pneumonia, Shigella, Clostridium Difficile, Other Pathogens
3) By Disease Type: Urinary Tract Infection, Intra-Abdominal Infection, Blood Stream infections, Clostridium Difficile Infections, Other Disease Types
4) By Mechanism Of Action: Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Other Mechanism Of Actions
5) By End Users: Hospitals, Homecare, Specialty Clinics, Other End-users
Subsegments:
1) By Beta Lactam Antibiotics: Penicillins, Cephalosporins, Carbapenems, Monobactams
2) By Cephalosporins: First-generation, Second-generation, Third-generation, Fourth-generation
3) By Quinolones Antibiotics: Fluoroquinolones, Other Quinolones
4) By Macrolide Antibiotics: Erythromycin, Azithromycin, Clarithromycin
5) By Tetracyclines: Doxycycline, Minocycline, Tetracycline
6) By Oxazolidinones: Linezolid, Tedizolid
7) By Other Drug Classes: Glycopeptides, Lipopeptides, Streptogramins, Polymyxins
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12131&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Antibiotic Resistance Market?# Market?
North America was the largest region in the antibiotic resistance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibiotic resistance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Most Significant Market Trends in the Antibiotic Resistance Market?
Within the antibiotic resistance market, product innovation is emerging as a significant trend. Leading corporations in this sector are making strides in producing groundbreaking products, aiming to cement their market status. For instance, Alkem Laboratories Limited, a pharmaceutical company hailing from India, launched Zidavi in January 2023. This novel antibiotic has been developed to combat multi-drug resistant (MDR) infections, with a goal to make it accessible, affordable, and readily available, thus potentially saving the lives of critically ill patients. The distinctive blend of ceftazidime and avibactam in Zidavi is designed to tackle infections triggered by MDR gram-negative pathogens. Each single-dose vial comes as a sterile powdered concentrate ready for infusion, containing of ceftazidime pentahydrate equivalent to 2 g ceftazidime and avibactam sodium equivalent to 0.5 g avibactam. It also presents a viable alternative treatment option for severe intra-abdominal infections (IAIs) and hospital-acquired pneumonia (HAP) caused by meropenem and colistin.
View the full report here:
https://www.thebusinessresearchcompany.com/report/antibiotic-resistance-global-market-report
What Parameters Are Used to Define the Antibiotic Resistance Market?
Antimicrobial resistance is a condition that occurs when microorganisms such as bacteria and fungi gain the capacity to resist medications that are meant to kill them. Resistance to infections is challenging to treat, leading to the death of an infected individual in the worst cases.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12131
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
